sotalol has been researched along with almokalant in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almgren, O; Carlsson, L; Duker, G | 1 |
| Grundke, M; Ravens, U; Wettwer, E | 1 |
| Gorgels, AP; Leunissen, JD; van der Zande, J; Verduyn, SC; Vos, MA; Wellens, HJ | 1 |
| Abrahamsson, C; Bäärnhielm, C; Carlsson, L; Danielsson, B; Duker, G; Ljung, B; Palmer, M | 1 |
| Brown-Woodman, PD; Danielsson, BR; Snow, MD; Webster, WS | 1 |
| Kulcsàr, A; van der Zande, J; Verduyn, SC; Vos, MA; Wellens, HJ | 1 |
| Farkas, A; Leprán, I; Papp, JG | 1 |
7 other study(ies) available for sotalol and almokalant
| Article | Year |
|---|---|
Electrophysiologic and hemodynamic effects of H 234/09 (almokalant), quinidine, and (+)-sotalol in the anesthetized dog.
Topics: Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Female; Hemodynamics; Male; Myocardial Contraction; Propanolamines; Quinidine; Sotalol | 1992 |
Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Guinea Pigs; In Vitro Techniques; Muscles; Piperidines; Potassium; Potassium Channels; Propanolamines; Pyridines; Quinidine; Sotalol; Time Factors | 1992 |
The effect of flunarizine and ryanodine on acquired torsades de pointes arrhythmias in the intact canine heart.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Channels; Disease Models, Animal; Dogs; Female; Flunarizine; Heart; Isoproterenol; Male; Propanolamines; Ryanodine; Sarcoplasmic Reticulum; Sotalol; Time Factors; Torsades de Pointes | 1995 |
Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Culture Techniques; Female; Fetal Death; Fetal Heart; Heart; Heart Rate; Myocardium; Phenethylamines; Pregnancy; Propanolamines; Rats; Rats, Sprague-Dawley; Sotalol; Sulfonamides | 1994 |
Teratogenic potential of almokalant, dofetilide, and d-sotalol: drugs with potassium channel blocking activity.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Arrhythmia Agents; Cleft Palate; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Female; Heart Rate, Fetal; Limb Deformities, Congenital; Male; Organ Culture Techniques; Phenethylamines; Potassium Channel Blockers; Pregnancy; Pregnancy Outcome; Propanolamines; Rats; Rats, Sprague-Dawley; Sotalol; Sulfonamides | 1996 |
Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own co
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Dogs; Electrocardiography; Female; Male; Propanolamines; Regression Analysis; Sotalol; Torsades de Pointes | 1997 |
Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Heart Rate; Infusions, Intravenous; Male; Phenylephrine; Propanolamines; Quinidine; Rabbits; Sotalol; Torsades de Pointes | 2002 |